Home › Comparisons › eVitalRx

Nesayo vs eVitalRx

Both are cloud pharmacy software. The differences are voice billing, reading a prescription photo, and which plans carry AI purchasing and distributor ordering. Updated September 2026.

Last reviewed 2026-09-30. Competitor data taken from https://evitalrx.in/.

Don't take our word for it — the quickest way to compare is to try both.

No download to install and no demo call to book: you can drive Nesayo right now — the real product on a sample pharmacy, no signup.

▶ Try the real Nesayo now — 60-sec tour

Feature by feature

FeatureNesayoeVitalRx
Deployment Cloud web app Cloud web app
Mobile billing Full PWA Web + mobile app
Voice billing English + Hindi + 8 regional languages (our AI and speech models) Not listed publicly as of September 2026
Prescription photo scan AI Vision reads the photo into a draft bill Not listed publicly as of September 2026
AI agents 5 autonomous scheduled agents SahaAI AI add-on — auto-pilot purchase (item + distributor selection, POs by email/WhatsApp), min-max, alerts
GST 5% + GSTR-1/3B Yes Yes
Distributor ordering integrated WhatsApp confirm link, ledger, credit limits Shortbook in all plans; auto PO and distributor selection through SahaAI, which is included from the Injection plan and a paid add-on on Capsule (per evitalrx.in/pricing, August 2026)
Pricing Billing free forever; AI Employee ₹999/mo (₹9,990/yr), as of September 2026 Annual plans (check evitalrx.in for current)
Founder story Team building software for Indian pharmacies Founded by Kaushal Shah (CEO & Founder), Ahmedabad

What "voice billing" actually covers, mechanically

This is worth spelling out because "voice billing" means different things depending on how deep the pipeline goes. The mechanical problem is that a pharmacist speaking naturally mixes languages mid-sentence — the medicine name stays in English or its trade name, but the quantity, dosage, and connecting words come out in Hindi, Tamil, Telugu, or whatever the counter's working language is. A voice input system that only handles clean English commands, or a single fixed language, breaks the moment real speech happens.

Nesayo's pipeline runs audio through our speech engine for transcription (which auto-detects the spoken language rather than assuming one), then our AI extracts medicine names and quantities from that transcript — including converting spoken numbers in Hindi and other Indian languages into digits, and matching medicine names against the catalog even when the transcription is imperfect. The practical result is a pharmacist can say a sentence that mixes English drug names with Hindi or regional-language quantities and numbers, and the system still produces a correct draft bill. Whether a given competitor's voice feature handles that mixed-language reality, or only clean single-language input, is the actual question worth testing with a real counter recording — not a demo video.

The background difference, and why it cuts both ways

It's worth being direct about this rather than glossing over it: eVitalRx is a pharmacy-first product that has been in the market for years, and that maturity is a real, earned advantage — years of use at real counters surface friction points a newer tool can miss. eVitalRx says it is trusted by 20,000+ pharmacists and chemists across India (its website, September 2026). Nesayo's team background leans toward AI research, which shows up as a different kind of strength: the voice pipeline, prescription-photo extraction, and the autonomous-agent architecture were built around recent AI capabilities from the start.

Neither background is strictly better; they produce different products with different blind spots. The practical way to use this difference isn't to pick a side based on background alone, but to actually test the specific thing each is supposed to be good at — a long-established pharmacy product on real operational workflow fit, an AI-first product on how well the voice/vision/agent features hold up against messy real input, not a clean demo.

Frequently asked questions

Should I switch from eVitalRx to Nesayo?

Switch if voice billing in Indian languages and reading medicines from a prescription photo matter at your counter — eVitalRx does not list either publicly as of September 2026. On eVitalRx, Tally integration is a paid add-on on the Capsule plan and included from the Injection plan (per its pricing page, August 2026); on Nesayo, Tally export comes with the AI Employee plan (₹999/month, as of September 2026), and billing itself is free. Run both in parallel for a week before deciding.

Is Nesayo newer than eVitalRx?

Yes. eVitalRx has been operating for several years and says it is trusted by 20,000+ pharmacists and chemists across India (its website, September 2026). Real pharmacies have billed on Nesayo since April 2026. Newer means Nesayo was built around voice billing, prescription-photo reading and scheduled AI agents from the start.

Can I import eVitalRx data into Nesayo?

Yes. Export your stock list from eVitalRx in whatever format your account allows; Nesayo imports CSV/Excel with auto-column detection, and our team can move your data across for you at no cost.

Which has better voice billing?

eVitalRx does not list voice billing publicly as of September 2026. Nesayo handles English, Hindi and Hinglish (voice beta) for quantity words (do/teen/paanch/rendu/eradu/don/dui/be/panj) while extracting English medicine names, via our AI and speech models auto-detection.

Not ready to switch? Free tools, no signup:

Check any medicine's Schedule (H1/H/X), look up its HSN code and GST rate, or decode a printed expiry date — nesayo.com/tools.

Try both. Keep what your pharmacist prefers.

Billing is free forever — sign up with no card.

Start free →

Disclaimer: This comparison is based on publicly-listed features and pricing of eVitalRx as of 2026-09-30. Vendors update their products frequently — always verify current features and pricing directly on the vendor's website. Nesayo has no commercial relationship with eVitalRx. No trademarks belonging to eVitalRx are used other than to identify the competitor product, which is permitted nominative fair use under Indian Trade Marks Act.